Heads of Medicines Agencies
From Wikipedia, the free encyclopedia
The Heads of Medicines Agencies (HMA) is a network of both the human and veterinary medicines agencies of the European Economic Area.[1]
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Predecessor | Heads of Agencies |
---|---|
Formation | 1996; 28 years ago (1996) |
Type | Governmental organization |
Purpose | Cooperation on the regulation of pharmaceutical drugs |
Region served | European Economic Area |
Website | www |
The HMA co-operates with the European Medicines Agency and the European Commission (Directorate-General for Health and Food Safety) in the operation of the European medicines regulatory system. The network provides a forum for the co-ordination and the exchange of views and proposals on issues concerning the European regulatory system and the role of the national authorities within that system.
The HMA, initially known as the Heads of Agencies, was established in 1995 with a first full meeting taking place in Amsterdam in February 1996. Initially the network comprised only agencies responsible for the regulation of medicines for human use. In February 1998, a parallel group bringing together the heads of agencies responsible for medicines for veterinary use held its first meeting. The two groups started organising joint meetings in 2000 and since 2004 these activities have been integrated under the umbrella of the HMA.